Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 25070877)

1.

Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies.

Assimakopoulos SF, Dimitropoulou D, Marangos M, Gogos CA.

Infection. 2014 Dec;42(6):951-9. doi: 10.1007/s15010-014-0666-5. Epub 2014 Jul 29.

PMID:
25070877
2.

Crosstalk between bioactive peptide and intestinal barrier in gut homeostasis.

Ji J, Qu H, Shu D.

Curr Protein Pept Sci. 2015 Jun 30. [Epub ahead of print]

PMID:
26122780
3.

Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation.

Routy JP, Mehraj V, Vyboh K, Cao W, Kema I, Jenabian MA.

AIDS Rev. 2015 May 6;17(2). [Epub ahead of print]

PMID:
25946417
4.

Serum-derived bovine immunoglobulin/protein isolate should be considered in patients with HIV gut barrier dysfunction.

Gelfand MS, Burnett BP.

Infection. 2015 Apr;43(2):253-4. doi: 10.1007/s15010-015-0732-7. Epub 2015 Jan 30. No abstract available.

PMID:
25633465
5.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

Jenabian MA, El-Far M, Vyboh K, Kema I, Costiniuk CT, Thomas R, Baril JG, LeBlanc R, Kanagaratham C, Radzioch D, Allam O, Ahmad A, Lebouché B, Tremblay C, Ancuta P, Routy JP; for the Montreal Primary infection and Slow Progressor Study Groups.

J Infect Dis. 2015 Jan 23. pii: jiv037. [Epub ahead of print]

PMID:
25616404
6.

HIV-associated mucosal gene expression: region-specific alterations.

Voigt RM, Keshavarzian A, Losurdo J, Swanson G, Siewe B, Forsyth CB, French AL, Demarais P, Engen P, Raeisi S, Mutlu E, Landay AL.

AIDS. 2015 Mar 13;29(5):537-46. doi: 10.1097/QAD.0000000000000569.

PMID:
25587909
8.

Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation.

Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, Estes JD, Sandler NG, Sukhumvittaya S, Marovich M, Jongrakthaitae S, Akapirat S, Fletscher JL, Kroon E, Dewar R, Trichavaroj R, Chomchey N, Douek DC, O Connell RJ, Ngauy V, Robb ML, Phanuphak P, Michael NL, Excler JL, Kim JH, de Souza MS, Ananworanich J; RV254/SEARCH 010 and RV304/SEARCH 013 Study Groups.

PLoS Pathog. 2014 Dec 11;10(12):e1004543. doi: 10.1371/journal.ppat.1004543. eCollection 2014 Dec.

9.

Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection.

Page EE, Greathead L, Metcalf R, Clark SA, Hart M, Fuchs D, Pantelidis P, Gotch F, Pozniak A, Nelson M, Boasso A, Gazzard B, Kelleher P.

J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):227-35. doi: 10.1097/QAI.0000000000000294.

PMID:
25314246
10.

Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.

Nouri M, Bredberg A, Weström B, Lavasani S.

PLoS One. 2014 Sep 3;9(9):e106335. doi: 10.1371/journal.pone.0106335. eCollection 2014.

11.
12.

Gut Microbiota in HIV Infection: Implication for Disease Progression and Management.

Nwosu FC, Avershina E, Wilson R, Rudi K.

Gastroenterol Res Pract. 2014;2014:803185. doi: 10.1155/2014/803185. Epub 2014 Jun 12. Review.

13.

Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients.

Kök A, Hocqueloux L, Hocini H, Carrière M, Lefrou L, Guguin A, Tisserand P, Bonnabau H, Avettand-Fenoel V, Prazuck T, Katsahian S, Gaulard P, Thiébaut R, Lévy Y, Hüe S.

Mucosal Immunol. 2015 Jan;8(1):127-40. doi: 10.1038/mi.2014.50. Epub 2014 Jul 2.

PMID:
24985081
14.

HIV enteropathy and aging: gastrointestinal immunity, mucosal epithelial barrier, and microbial translocation.

Wang H, Kotler DP.

Curr Opin HIV AIDS. 2014 Jul;9(4):309-16. doi: 10.1097/COH.0000000000000066. Review.

PMID:
24871087
15.

Unraveling the relationship between microbial translocation and systemic immune activation in HIV infection.

Shan L, Siliciano RF.

J Clin Invest. 2014 Jun;124(6):2368-71. doi: 10.1172/JCI75799. Epub 2014 May 16.

16.

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.

Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N.

Front Immunol. 2014 Apr 22;5:180. doi: 10.3389/fimmu.2014.00180. eCollection 2014. Review.

17.

Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.

Hunt PW, Sinclair E, Rodriguez B, Shive C, Clagett B, Funderburg N, Robinson J, Huang Y, Epling L, Martin JN, Deeks SG, Meinert CL, Van Natta ML, Jabs DA, Lederman MM.

J Infect Dis. 2014 Oct 15;210(8):1228-38. doi: 10.1093/infdis/jiu238. Epub 2014 Apr 21.

PMID:
24755434
18.

Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?

George MD, Asmuth DM.

Curr Opin Infect Dis. 2014 Jun;27(3):275-81. doi: 10.1097/QCO.0000000000000059. Review.

PMID:
24739345
19.

Intestinal epithelial barrier disruption through altered mucosal microRNA expression in human immunodeficiency virus and simian immunodeficiency virus infections.

Gaulke CA, Porter M, Han YH, Sankaran-Walters S, Grishina I, George MD, Dang AT, Ding SW, Jiang G, Korf I, Dandekar S.

J Virol. 2014 Jun;88(11):6268-80. doi: 10.1128/JVI.00097-14. Epub 2014 Mar 26.

20.

Systemic immune activation in HIV and potential therapeutic options.

Sinha B, Rubens M.

Immunopharmacol Immunotoxicol. 2014 Apr;36(2):89-95. doi: 10.3109/08923973.2014.890217. Epub 2014 Feb 20. Review.

PMID:
24552614
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk